Asegurar que el tratamiento del VIH llegue a todas las personas que lo necesitan en América Latina y el Caribe, es uno de los desafíos que la región enfrenta en la actualidad.

In Latin America and the Caribbean there is limited knowledge about the extent of co-infection of viral hepatitis and HIV, even though they have similar epidemiological characteristics, so strategic measures are needed to prevent and control the problem...

WHO has issued its first guidance to countries that are considering offering HIV medications, known as antiretrovirals (ARVs), to protect people who do not have the virus but who are at high risk of HIV infection.

Increased use of HIV treatment known as antiretrovirals (ARVs) in low- and middle-income countries has resulted in resistance to some forms of treatment, but not to the extent seen when HIV medication was first introduced in high-income countries in the 1990s, according to a new report from WHO.

More strategic use of antiretroviral HIV medications can significantly reduce the transmission of the virus according to WHO proposals that will be presented at the XIX International AIDS Conference in Washington, DC on Sunday.